Journal
NATURE BIOMEDICAL ENGINEERING
Volume 1, Issue 9, Pages 724-735Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41551-017-0128-3
Keywords
-
Categories
Funding
- National Science Foundation [ECCS-1607250]
- National Institutes of Health [NIBIB-1R21EB016783]
- National Natural Science Foundation of China [61471254]
- Div Of Electrical, Commun & Cyber Sys
- Directorate For Engineering [1607250] Funding Source: National Science Foundation
Ask authors/readers for more resources
Detection of nuclear biomarkers, such as nucleic acids and nuclear proteins, is critical for early-stage cancer diagnosis and prognosis. Conventional methods relying on morphological assessment of cell nuclei in histopathology slides may be subjective, whereas colorimetric immunohistochemical and fluorescence-based imaging are limited by strong light absorption, broad emission bands and low contrast. Here, we describe the development and use of a scanning laser-emission-based microscope that maps lasing emissions from nuclear biomarkers in human tissues. Forty-one tissue samples from 35 patients labelled with site-specific and biomarker-specific antibody-conjugated dyes were sandwiched in a Fabry-Perot microcavity while an excitation laser beam built a laser-emission image. We observed multiple subcellular lasing emissions from cancer cell nuclei, with a threshold of tens of mu J mm(-2), submicrometre resolution (<700 nm), and a lasing band in the few-nanometre range. Different lasing thresholds of nuclei in cancer and normal tissues enabled the identification and multiplexed detection of nuclear proteomic biomarkers, with high sensitivity for early-stage cancer diagnosis. Laser-emission-based cancer screening and immunodiagnosis might find use in precision medicine and facilitate research in cell biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available